Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-103-1 | CAS number: 3349-36-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin:
The following study was submitted as the key study:
Sanders, A (2010) ACUTE DERMAL TOXICITY (LIMIT TEST) IN THE RAT. Harlan Laboratories Limited, Shardlow Business Park, Shardlow, Derbyshire, DE72 2GD, UK. Owner company: Chemtura Corporation, 199 Benson Road, Middlebury, CONNECTICUT 06749, USA. Report No.: 41003850.
Two in vitro studies were provided as supporting information:
Warren, N (2010) IN VITRO SKIN CORROSION IN THE EPISKIN(TM) RECONSTITUTED HUMAN EPIDERMIS MODEL. Harlan Laboratories Limited, Shardlow Business Park, Shardlow, Derbyshire, DE72 2GD, UK. Owner company: Chemtura Corporation, 199 Benson Road, Middlebury, CONNECTICUT 06749, USA. Report No.: 3103/0039.
Warren, N (2010) DETERMINATION OF SKIN IRRITATION POTENTIAL USING THE EPISKIN(TM) RECONSTITUTED HUMAN EPIDERMIS MODEL. Harlan Laboratories Limited, Shardlow Business Park, Shardlow, Derbyshire, DE72 2GD, UK. Owner company: Chemtura Corporation, 199 Benson Road, Middlebury, CONNECTICUT 06749, USA. Report No.: 3103/0040.
The 2 in vitro studies, were assigned a reliability score of 1, both were conducted to GLP & to a validated method. The acute dermal toxicity study was assigned a score of 2 as the method was not a standard irritation/corrosion test.
Eye:
The Sanders, 2010 study (in vivo eye irritation) was provided as the key study
A Sanders (2010) ACUTE EYE IRRITATION IN THE RABBIT. Harlan Laboratories Limited, Shardlow Business Park, Shardlow, Derbyshire, DE72 2GD UK.
Two in vitro studies were also presented; Warren, N (2010) ASSESSMENT OF OCULAR IRRITATION POTENTIAL USING THE SKINETHIC RECONSTITUTED HUMAN CORNEAL EPITHELIUM MODEL, PROJECT No.: 3103/0041 & Warren, N (2010) THE BOVINE CORNEAL OPACITY AND PERMEABILITY ASSAY (BCOP), PROJECT No.: 41003513.
The Sanders, 2010 study and the Warren, 2010, BCOP study were assigned a reliability score of 1 as they were conducted to OECD guidelines & GLP. The other in vitro study was assigned a score of 2 as it is a pre-validated study.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was performed between 22 September 2010 and 29 September 2010.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was performed to the OECD testing guideline for acute dermal toxicity. The study was performed in compliance with GLP.
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- Principles of method if other than guideline:
- The study was performed to the OECD guideline 402 to determine the acute dermal toxicity of the substance.
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories U.K. Ltd., Oxon, UK.
- Age at study initiation: eight to twelve weeks of age
- Weight at study initiation: animals weighed at least 200g
- Housing: The animals were housed in suspended solid floor polypropylene cages furnished with woodflakes.
- Diet/water (e.g. ad libitum): Free access to mains drinking water and food (2014 Teklad Global Rodent diet supplied by Harlan Laboratories U.K. Ltd., Oxon, UK) was allowed throughout the test. The diet, drinking water and bedding were routinely analysed and were considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.
- Acclimation period: acclimatisation period of at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25°C
- Humidity (%): 30 to 70%
- Air changes (per hr): at least fifteen changes per hour
- Photoperiod (hrs dark / hrs light): lighting was controlled by a time switch to give twelve hours continuous light (06:00 to 18:00) and twelve hours darkness. - Type of coverage:
- semiocclusive
- Preparation of test site:
- shaved
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not specified
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 1.77 ml/kg (dose 2000 mg/kg bw) - Duration of treatment / exposure:
- 24 hours
- Observation period:
- 7 days
- Number of animals:
- 2
- Details on study design:
- TEST SITE
- % coverage: The calculated volume of test material, as received, was applied as evenly as possible to an area of shorn skin (approximately 10% of the total body surface area) using a graduated syringe.
- Type of wrap if used: A piece of surgical gauze was placed over the treatment area and semi-occluded with a piece of self adhesive bandage.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): After the 24-Hour contact period the bandage was carefully removed and the treated skin and surrounding hair wiped with cotton wool moistened with arachis oil BP to remove any residual test material.
OBSERVATIONS
- Time after start of exposure: 24 hours
- Duration of observation period following administration: 7 days
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity ½, 1, 2 and 4 hours after dosing and subsequently once daily for seven days. Individual bodyweights were recorded prior to application of the test material on Day 0 and death (Day 7).
- Necropsy of survivors performed: yes
- Other examinations performed: All animals were subjected to gross necropsy. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. No tissues were retained. - Irritant / corrosive response data:
- Dermal Reactions
Individual dermal reactions are given in Table 2.
Signs of dermal irritation noted were very slight or well-defined erythema and hardened dark brown black coloured scab were noted at both test sites. Additional signs of dermal irritation noted at the test site of the male were hardened light brown coloured scab and scab cracking. Additional signs of dermal irritation noted in the female were haemorrhage of dermal capillaries, hardened light brown coloured scab, small areas of pale green coloured dermal necrosis scattered around the edges of the test site, blanching of the skin and hardened dark brown coloured scab, approximately 10 mm x 20 mm in size, surrounded by loss of skin elasticity and light brown discolouration of the epidermis. Adverse dermal reactions prevented accurate evaluation of erythema and oedema at both test sites six and seven days after dosing. The reactions noted in the male were considered to be indicative of dermal corrosion. - Other effects:
- Mortality Data: Both animals were killed for humane reasons seven days after dosing, due to the approach of the moderate severity limit set by the UK Home Office.
Clinical Observations: Signs of systemic toxicity noted were hunched posture, pilo-erection, lethargy, dehydration and pallor of the extremities.
Bodyweight: Bodyweight loss was noted over the study period.
Necropsy: Raised limiting ridge of the stomach and scattered dermal haemorrhage at the sub cutaneous site of application were noted at necropsy.
- Interpretation of results:
- corrosive
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- Signs of dermal irritation noted were Very slight or well-defined erythema and hardened dark brown black coloured scab were noted at both test sites. Additional signs of dermal irritation noted at the test site of the male were hardened light brown coloured scab and scab cracking. Additional signs of dermal irritation noted in the female were haemorrhage of dermal capillaries, hardened light brown coloured scab, small areas of pale green coloured dermal necrosis scattered around the edges of the test site, blanching of the skin and hardened dark brown coloured scab, approximately 10 mm x 20 mm in size, surrounded by loss of skin elasticity and light brown discolouration of the epidermis. Adverse dermal reactions prevented accurate evaluation of erythema and oedema at both test sites six and seven days after dosing. The reactions noted in the male were considered to be indicative of dermal corrosion.
- Executive summary:
The study was performed to assess the acute dermal toxicity of the test item in the Wistar strain rat. The method was designed to meet the requirements of the following:
OECD Guidelines for the Testing of Chemicals No. 402 “Acute Dermal Toxicity” (adopted 24 February 1987)
Method B3 Acute Toxicity (Dermal) of Commission Regulation (EC) No. 440/2008
Initially, two animals (one male and one female) were given a single, 24-hour, semi-occluded dermal application of the undiluted test item to intact skin at a dose level of 2000 mg/kg bodyweight. Based on the results of the initial test, no further animals were treated.
Signs of dermal irritation noted were well-defined erythema, haemorrhage of dermal capillaries, hardened light brown, dark brown or dark brown black coloured scab, scab cracking, blanching of the skin, loss of skin elasticity, light brown discolouration of the epidermis and small areas of pale green coloured dermal necrosis.
The reactions noted in the male were considered to be indicative of dermal corrosion.
Reference
Due to severe/corrosive dermal reactions no further animals were treated with the test item.
Table 1 Individual Clinical Observations and Mortality Data
Dose Level mg/kg |
Animal Number and Sex |
Effects Noted After Initiation of Exposure (Hours) |
Effects Noted After Initiation of Exposure (Days) |
|||||||||
½ |
1 |
2 |
4 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
||
2000 |
1-0 Male |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
H |
HPDh |
HPDhEX* |
2-0 Female |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
H |
HPLDh |
HPLDhEX* |
0 = No signs of systemic toxicity
H = Hunched posture
P = Pilo-erection
L = Lethargy
Dh = Dehydration
E = Pallor of the extremities
X* = Animal killed for humane reasons due to the approach of the moderate severity limit set by the UK Home Office
Table 2 Individual Dermal Reactions
Dose Level mg/kg |
Animal Number and Sex |
Observation |
Effects Noted After Initiation of Exposure (Days) |
||||||||||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
|||||||||||||
2000 |
1-0 Male |
Erythema |
0 |
1 |
1 |
1 |
1 |
?e |
?e |
||||||||||
Oedema |
0 |
0 |
0 |
0 |
0 |
?od |
?od |
||||||||||||
Other |
0 |
0 |
0 |
0 |
0 |
St |
SpSk |
||||||||||||
2-0 Female |
Erythema |
1 |
1 |
0 |
0 |
0 |
?e |
?e |
|||||||||||
Oedema |
0 |
0 |
0 |
0 |
0 |
?od |
?od |
||||||||||||
Other |
0 |
0 |
0 |
Hd |
Hd |
St |
NBlSt*LeBr |
0 = No reactions
Hd = Haemorrhage of dermal capillaries
St = Hardened dark brown black coloured scab
Sp = Hardened light brown coloured scab
Sk = Scab cracking
N = Small areas of pale green coloured dermal necrosis scattered around the edges of the test site
Bl = Blanching of the skin
St* = Hardened dark brown coloured scab, approximately 10 mm x 20 mm in size
Le = Loss of skin elasticity
Br = Light brown discolouration of the epidermis
?e = Adverse dermal reactions prevent accurate evaluation of erythema
?od = Adverse dermal reactions prevent accurate evaluation of oedema
Table 3 Individual Bodyweights and Weekly Bodyweight Changes
Dose Level mg/kg |
Animal Number and Sex |
Bodyweight (g) at Day |
At Death |
Bodyweight Change (g) During Week |
|||
0 |
7 |
14 |
1 |
2 |
|||
2000 |
1-0 Male |
223 |
- |
- |
166 |
- |
- |
2-0 Female |
211 |
- |
- |
160 |
- |
- |
- = Animal dead
Table 4 Individual Necropsy Findings
Dose Level mg/kg |
Animal Number |
Time of Death |
Macroscopic Observations |
2000 |
1-0 Male |
Humanely killed Day 7 |
Stomach: raised limiting ridge Sub-cutaneous at the site of application: scattered dermal haemorrhage |
2-0 Female |
Humanely killed Day 7 |
Stomach: raised limiting ridge Sub-cutaneous at the site of application: scattered dermal haemorrhage |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (corrosive)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was performed between 22 September 2010 and 23 September 2010.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study conducted to GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- Deviations:
- no
- Principles of method if other than guideline:
- An assessment of the initial pain reaction was not performed. This deviation from the General Study Plan was considered not to affect the purpose or integrity of the study.
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories U.K. Ltd., Loughborough, UK.
- Age at study initiation: twelve to twenty weeks old
- Weight at study initiation: 2.52 kg
- Housing: The animal was housed in a suspended cage.
- Diet/water (e.g. ad libitum): Free access to mains drinking water and food (2030 Teklad Global Rabbit diet supplied by Harlan Laboratories U.K. Ltd., Oxon, UK) was allowed throughout the study. The diet and drinking water were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23°C
- Humidity (%): 30 to 70%
- Air changes (per hr): The rate of air exchange was at least fifteen changes per hour
- Photoperiod (hrs dark / hrs light): lighting was controlled by a time switch to give twelve hours continuous light (06:00 to 18:00) and twelve hours darkness. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): A volume of 0.1 ml of the test material was placed into the conjunctival sac of the right eye, formed by gently pulling the lower lid away from the eyeball. - Duration of treatment / exposure:
- The upper and lower eyelids were held together for about one second immediately after treatment, to prevent loss of the test material, and then released.
- Observation period (in vivo):
- Assessment of ocular damage/irritation was made approximately 1 hour and 24 hours.
- Number of animals or in vitro replicates:
- 1
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): none
- Time after start of exposure: n/a
SCORING SYSTEM: Assessment of ocular damage/irritation was made approximately 1 and 24 hours following treatment, according to the numerical evaluation given in Appendix 1, (from Draize J H (1977) "Dermal and Eye Toxicity Tests" In: Principles and Procedures for Evaluating the Toxicity of Household Substances, National Academy of Sciences, Washington DC p.48 to 49).
TOOL USED TO ASSESS SCORE: Examination of the eye was facilitated by the use of the light source from a standard ophthalmoscope. - Irritation parameter:
- cornea opacity score
- Remarks:
- degree of opacity
- Basis:
- animal #1
- Time point:
- other: 24 hours
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- not reversible
- Irritation parameter:
- cornea opacity score
- Remarks:
- area of cornea involved
- Basis:
- animal #1
- Time point:
- other: 24 hours
- Score:
- 4
- Max. score:
- 4
- Reversibility:
- not reversible
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- other: 24 hours
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- not reversible
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #1
- Time point:
- other: 24 hours
- Score:
- 3
- Max. score:
- 3
- Reversibility:
- not reversible
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- other: 24 hours
- Score:
- 3
- Max. score:
- 4
- Reversibility:
- not reversible
- Irritant / corrosive response data:
- Severe conjunctival irritation was noted in the treated eye one hour after treatment. Scattered or diffuse corneal opacity, iridial inflammation and severe conjunctival irritation were noted in the treated eye at the 24-Hour observation.
- Other effects:
- Other ocular effects noted at the 24-Hour observation were haemorrhage of the upper and lower conjunctival membranes and blood stained discharge from the conjunctival and nictitating membranes.
- Interpretation of results:
- Category 1 (irreversible effects on the eye) based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- The test item was considered to be corrosive to the rabbit eye.
- Executive summary:
The study was performed to assess the irritancy potential of the test item to the eye of the New Zealand White rabbit. The method was designed to meet the requirements of the following:
- OECD Guidelines for the Testing of Chemicals No. 405 “Acute Eye Irritation/Corrosion” (adopted)
- Method B5 Acute Toxicity (Eye Irritation) of CommissionRegulation (EC) No. 440/2008
A single application of the test item to the non-irrigated eye of one rabbit produced scattered or diffuse corneal opacity, iridial inflammation, severe conjunctival irritation, haemorrhage of the conjunctival and nictitating membranes and blood stained discharge. Due to the severity of the reactions the animal was killed for humane reasons immediately after the 24-hour observation in accordance with current UK Home Office guidelines.
Based on the results of the study the test item was considered to be corrosive to the rabbit eye, in addition, the test item was considered to be an irritant according to EU labelling regulations Commission Directive 2001/59/EC. It is reasonable to assume that the symbol “Xi”, the indication of danger “Irritant” and the highest risk phrase R 41 “RISK OF SERIOUS DAMAGE TO EYES” are therefore required.
Reference
Due to the severity of the reactions the animal was killed for humane reasons immediately after the 24 hour observation in accordance with current UK Home Office guidelines.
Table 1 Individual Scores for Ocular Irritation
Rabbit Number and Sex |
69630 Male |
|
Time After Treatment |
1 Hour |
24 Hours |
CORNEA |
|
|
Degree of Opacity |
0 |
1 |
Area of Cornea Involved |
0 |
4 |
IRIS |
0 |
1 |
CONJUNCTIVA |
|
|
Redness |
2 |
3HBs |
Chemosis |
3 |
3 |
Discharge |
3 |
3 |
H = Haemorrhage of the upper and lower conjunctival membranes
Bs = Blood stained discharge from the conjunctival and nictitating membranes
Table 2 Individual Bodyweights and Bodyweight Changes
Rabbit Number |
Individual Bodyweight (kg) |
Bodyweight Change (kg) |
|
Day 0 |
Day 1 |
||
69630Male |
2.52 |
2.46 |
-0.06 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
Skin:
This endpoint was addressed with the submission of an acute dermal toxicity study which included observations of local effects suitable for assessment under this endpoint. This was the only available in vivo study which included demonstrable effects. Two further in vitro studies were provided as supporting information.
Sanders A (2010) was provided as the key study. The study was performed to GLP and as it was performed to the standard guidelines for acute dermal toxicity, the observations of local dermal effects were considered to have been performed in line with good scientific principles and therefore assigned a reliability score of 2 according to the criteria outlined in Klimisch (1997). As the only available in vivo study, with clear demonstrable effects, the study was selected as the key study. The study was performed to assess the acute dermal toxicity of the test material in the Wistar strain rat (Performed to OECD Guidelines for the Testing of Chemicals No. 402 "Acute Dermal Toxicity" (adopted 24 February 1987) and Method B3 Acute Toxicity (Dermal) of Commission Regulation (EC) No. 440/2008). Two animals (one male and one female) were given a single, 24-Hour, semi-occluded dermal application of the undiluted test material to intact skin at a dose level of 2000 mg/kg bodyweight. Signs of dermal irritation noted loss of skin elasticity, hardened dark brown/black coloured scab, small areas of pale green coloured dermal necrosis scattered around the edges of the test site, scab cracking. Adverse skin reactions prevented accurate evaluation of erythema and oedema at both test sites during the study. The reactions were considered to be indicative of dermal corrosion.
- The Warren (2010), study investigating skin corrosivity (designed to meet the requirements of the OECD Guideline for the Testing of Chemicals No. 431 “In Vitro Skin Corrosion: Human Skin Model Test” (adopted 13 April 2004).) was assigned a reliability rating of 1 was assigned according to the criteria of Klimisch, 1997 as this was conducted to a guideline study and GLP. The purpose of this test was to evaluate the corrosivity potential of the test material using the EPISKIN(TM) in vitro Reconstituted Human Epidermis (RHE) Model after treatment periods of 3, 60 and 240 minutes. This method was designed to meet the requirements of the OECD Guideline for the Testing of Chemicals No. 431 “In Vitro Skin Corrosion: Human Skin Model Test” (adopted 13 April 2004).
The test material was considered to be Non-Corrosive to the skin and accredited the EU risk phrase of No label and a UN packing group Non-Corrosive.
- The Warren (2010) study investigating skin irritancy (according to a validated in vitro method following the EPISKINTM reconstituted human epidermis model.) was assigned a reliability rating of 1 was assigned according to the criteria of Klimisch, 1997 as this was conducted to a validated in vitro method and GLP. The purpose of this test was to evaluate the skin irritation potential of the test material using the EPISKINTM reconstituted human epidermis model after a treatment period of 15 minutes followed by a post exposure incubation period of 42 hours.
The test material was considered to be Irritant (I).
Eye:
In two in vitro eye irritation studies (Warren, 2010) the test material was assessed using the SkinEthic Reconstituted Human Corneal model and the Bovine Corneal Opacity and Permeability assay. According to the protocols followed the test material was considered to be Non-Irritant and so an in vivo test was carried out.
In the in vivo study (Sanders, 2010) the study was performed to assess the irritancy potential of the test material to the eye of the New Zealand White rabbit.
A single application of the test item to the non-irrigated eye of one rabbit produced scattered or diffuse corneal opacity, iridial inflammation, severe conjunctival irritation, haemorrhage of the conjunctival and nictitating membranes and blood stained discharge. Due to the severity of the reactions the animal was killed for humane reasons immediately after the 24-hour observation in accordance with current UK Home Office guidelines.
Based on the results of the study the test item was considered to be corrosive to the rabbit eye
The results from the in vitro studies do not correlate with the key study.
Effects on skin irritation/corrosion: corrosive
Effects on eye irritation: highly irritating
Justification for classification or non-classification
Skin corrosivity:
As a precautionary measure the substance has been classified as corrosive to the skin based on a dermal study, although it should be noted that the test material was left on for 24 hours which is longer than the 4-hours given in recognised guidelines for this endpoint, also the corrosion is not seen straight away after exposure, signs of corrosion are not noted until after day 5.
The study does not technically fit the criteria for "corrosive" with regards to Directive 67/548/EEC and also Regulation (EC) no 1272/2008, however corrosive effects are seen in this study around 5 day. Expert judgement has been applied to classify this substance as corrosive.
The test material was considered to be corrosive to the skin. The substance was assigned a classification of Category 1C Corrosive with the risk phrase H314 and the signal "Danger" under the regulation (EC) No.: 1272/2008 and accordingly under the directive 67/548/EEC as C (corrosive) R34 (Causes burns).
Eye:
Following assessment of the in vivo data, the test material was considered to cause severe ocular irritancy in vivo.
Based on the results of the study the test item was considered to be corrosive to the rabbit eye, in addition, the test item was considered to be an irritant according to EU labelling regulations Commission Directive 2001/59/EC. It is reasonable to assume that the symbol “Xi”, the indication of danger “Irritant” and the highest risk phrase R 41 “RISK OF SERIOUS DAMAGE TO EYES” are therefore required. According to the regulation (EC) No.: 1272/2008, the test material is a Category 1 irritant and so will have the hazard statement H318: causes serious eye damage and the 'Danger' symbol.
However, according to Section 3.2.6.2 of Directive 67/548/EEC when a substance is classified as R34, the risk of severe damage to eyes is considered implicit and R41 is not included in the label. Likewise under the regulation (EC) No.: 1272/2008, Section 3.3.2.3 skin corrosive substances shall be considered as leading to serious damage to the eyes as well (Category 1) and hence H318 is not included in the label.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.